WebRay Dingledine is a professor in the Department of Pharmacology at Emory. His current research focuses on the regulation of glutamate receptor-mediated synaptic transmission … WebRay Dingledine's 9 research works with 75 citations and 352 reads, including: Phase 1 Clinical Results for NP10679, a pH‐sensitive GluN2B‐selective N‐methyl‐d‐aspartate …
Meet Our Team of Neurosurgeons and Neurologists at …
WebJan 1, 2014 · Ray Dingledine first met Phil Schwartzkroin in 1975 just after Phil had returned to Stanford from his postdoctoral stint with Per Andersen in Oslo, ... Department of … http://journals.ed.ac.uk/gtopdb-cite/article/view/6414 sperry classic brown
When and how do seizures kill neurons, and is cell death relevant …
WebRay Dingledine was interviewed by International Innovation magazine. Read the interview which includes Dr. Dingledine's insight into the field of pharmacology and a new route to clinical treatment of epilepsy and brain injury. Ray Dingledine discusses the impact sequestration budget cuts could have on medical research at Emory and nationally. WebJan 6, 2024 · Activation of prostanoid EP2 receptor exacerbates neuroinflammatory and neurodegenerative pathology in central nervous system diseases such as epilepsy, … WebA compound found in trace amounts in alcoholic beverages is more effective at combating seizures in rats exposed to an organophosphate nerve agent than the current … sperry cleaner and conditioner